Allianz Asset Management GmbH - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 334 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q2 2024$5,428,871
+20.8%
205,873
+39.1%
0.01%
+14.3%
Q1 2024$4,494,851
+145.9%
148,003
+127.4%
0.01%
+133.3%
Q4 2023$1,828,154
-43.3%
65,082
-45.3%
0.00%
-40.0%
Q3 2023$3,226,512
+23.1%
118,884
+39.4%
0.01%0.0%
Q2 2023$2,620,769
-37.4%
85,256
-26.6%
0.01%
-28.6%
Q1 2023$4,187,731
-20.5%
116,229
-12.8%
0.01%
-30.0%
Q4 2022$5,268,846
+6.0%
133,321
+7.8%
0.01%0.0%
Q3 2022$4,969,000
+105.9%
123,673
+115.5%
0.01%
+400.0%
Q2 2022$2,413,000
+164.9%
57,382
+145.2%
0.00%
+100.0%
Q1 2022$911,000
-18.1%
23,405
-16.2%
0.00%0.0%
Q4 2021$1,113,000
+82.5%
27,917
+65.3%
0.00%
Q3 2021$610,000
+45.6%
16,885
+65.2%
0.00%
Q2 2021$419,000
+94.0%
10,223
+106.0%
0.00%
Q1 2021$216,000
-12.9%
4,9630.0%0.00%
Q4 2020$248,0004,9630.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2022
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$263,446,00059.92%
Memorial Sloan Kettering Cancer Center 1,128,255$43,957,00050.90%
Vantage Consulting Group Inc 2,727,854$106,277,00041.47%
Indie Asset Partners, LLC 756,874$29,488,00022.15%
Overbrook Management Corp 723,250$28,178,0006.25%
Brown University 621,759$24,224,0005.93%
Geo Capital Gestora de Recursos Ltd 200,692$8,527,0003.82%
Lagoda Investment Management, L.P. 141,560$5,515,0002.97%
Greytown Advisors Inc. 131,143$5,109,0002.47%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,025,610$78,918,0002.41%
View complete list of ROYALTY PHARMA PLC shareholders